Cytokinetics Inc Annual Shareholders Meeting Transcript
(technical difficulty) Chairman of Cytokinetics Board of Directors, and I welcome you to our 2022 Annual Meeting of Stockholders. The meeting is now called to order. John Faurescu, Vice President, Corporate and Legal and Assistant Secretary, will record in the minutes.
Before proceeding to the formal business, let me introduce Robert Blum, the company's President and Chief Executive Officer, who will provide an overview of our plans for 2022 after our formal proceedings. Before proceeding, I am pleased to introduce the members of the company's management joining us today. Ching Jaw, Senior Vice President, Chief Financial Officer; Diane Weiser, Senior Vice President, Corporate Communications and Investor Relations; and Robert Wong, Vice President, Chief Accounting Officer.
I would also like to introduce Marcus Linder from Ernst & Young LLP, the company's independent registered public accounting firm, who is available to respond to appropriate questions.
Before I hand over the meeting to John
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |